| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1009805997 |
| P356 | DOI | 10.1046/J.1523-1755.2002.00215.X |
| P698 | PubMed publication ID | 11849469 |
| P5875 | ResearchGate publication ID | 11512810 |
| P2093 | author name string | Hiromichi Kumagai | |
| Akira Hishida | |||
| Akihiko Kato | |||
| Takako Takita | |||
| Yukitaka Maruyama | |||
| Mari Odamaki | |||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hemodialysis patient | Q126109077 |
| interleukins | Q194908 | ||
| atherosclerosis | Q12252367 | ||
| P304 | page(s) | 1143-1152 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Kidney International | Q6404823 |
| P1476 | title | Association between interleukin-6 and carotid atherosclerosis in hemodialysis patients | |
| P478 | volume | 61 |
| Q46694729 | An association between inflammatory state and left ventricular hypertrophy in hemodialysis patients |
| Q92051909 | Assessment of Sclerostin and Interleukin 6 Levels and Selected Anthropometric Parameters in Patients Receiving Hemodialysis Replacement Therapy-Pilot Study |
| Q47863611 | Association between chronic hepatitis C infection and coronary flow reserve in dialysis patients with failed renal allografts |
| Q37862690 | Associations of serologic markers of infection and inflammation with vascular disease events and mortality in American dialysis patients |
| Q35758705 | Chlamydia pneumoniae and atherosclerosis: no way-out or long way? What about renal failure patients? |
| Q35715691 | Comparative effects of angiotensin-converting enzyme inhibition and angiotensin-receptor blockade on inflammation during hemodialysis. |
| Q36176347 | Correlation of Inflammation and Lipoprotein (a) with Hypercoagulability in Hemodialysis Patients |
| Q35644319 | Correlative association of interleukin-6 with intima media thickness: a meta-analysis. |
| Q51466732 | Differential associations of traditional and non-traditional risk factors with carotid intima-media thickening and plaque in peritoneal dialysis patients. |
| Q36721848 | Genomic damage and malignancy in end-stage renal failure: do advanced glycation end products contribute? |
| Q48006325 | Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease |
| Q73758240 | Linkage of hypoalbuminemia, inflammation, and oxidative stress in patients receiving maintenance hemodialysis therapy |
| Q35562015 | Oxidative stress in uremia |
| Q47862138 | Plasma ghrelin levels are associated with coronary microvascular and endothelial dysfunction in peritoneal dialysis patients |
| Q44780252 | Plasma interleukin-6 is independently associated with mortality in both hemodialysis and pre-dialysis patients with chronic kidney disease |
| Q42131539 | Pravastatin prevents aortic atherosclerosis via modulation of signal transduction and activation of transcription 3 (STAT3) to attenuate interleukin-6 (IL-6) action in ApoE knockout mice |
| Q44538409 | Risk factors for aortic atherosclerosis determined by transesophageal echocardiography in patients with CRF. |
| Q58051983 | Serum levels of anticyclic citrullinated peptide antibodies, interleukin-6, tumor necrosis factor-α, and C-reactive protein are associated with increased carotid intima-media thickness: a cross-sectional analysis of a cohort of rheumatoid arthritis |
| Q41763608 | The influence of risk factors in remodelling carotid arteries in patients undergoing peritoneal dialysis |
| Q35563082 | Uremic malnutrition-inflammation syndrome in chronic renal disease: a pathobiologic entity |
Search more.